Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0000919574-17-006374

Director bought 10,000 shares at $2.60 ($25,955)

From the SEC's structured data for this filing

Trades in this filing

BROADWOOD PARTNERS, L.P. · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-08-22 Purchase : show line 1 in the form +10,000 $2.60 $25,955 27,279,254 D
2017-08-22 Purchase : show line 2 in the form +0 27,279,254 I
Open-market purchases · 10,000 sh · avg $2.60 · $25,955
Loading xslF345X03/p7599978.xml…